The placebo-controlled, multinational, double-blind trial enrolled 1,150 participants. Credit: R Photography Background / ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

Tango Therapeutics has announced the first subject dosing in the open-label, multi-centre TNG456 Phase I/II trial.

Satellos said that following the Phase I data, it will be advancing its DMD small molecule to a Phase II trial.

Merck KGaA said that cohort A met the primary endpoint in the Phase II lupus trial but cohort B failed to meet its primary ...

Olezarsen is a promising treatment for severe hypertriglyceridemia, familial chylomicronemia syndrome and other dyslipidemia.

AnnJi Pharmaceutical has reported encouraging outcomes from its randomised, placebo-controlled Phase I/IIa trial of AJ201.

The US FDA has cleared Grifols' investigational new drug (IND) application to commence a Phase II trial of GRF312 Ophthalmic ...

Member states of the World Health Organization (WHO) have recently agreed on the world's first Pandemic Agreement.

Queen's Health Sciences (QHS) in Canada has announced the launch of a centralised Clinical Trial Support Unit (CTSU).

KaliVir Immunotherapeutics has concluded the first cohort in the Phase I/Ib STEALTH-001 trial evaluating VET3-TGI for ...

The shift toward patient-centric trials is real, but challenges in enrolment and retention persist. Patient-centricity has ...